Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2019. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3699106018 | Product containing precisely lidocaine hydrochloride 20 milligram/2 milliliter and methylprednisolone acetate 80 milligram/2 milliliter conventional release suspension for injection vial (clinical drug) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3699107010 | Lidocaine hydrochloride 20 mg/2 mL and methylprednisolone acetate 80 mg/2 mL suspension for injection vial | en | Synonym (core metadata concept) | Active | Only initial character case insensitive (core metadata concept) | SNOMED CT core |
| 4177901000052112 | lidokainhydroklorid 20 mg/2 ml + metylprednisolonacetat 80 mg/2 ml, injektionsvätska, suspension, flaska | sv | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT Sweden NRC maintained module (core metadata concept) |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| lidokainhydroklorid 20 mg/2 ml + metylprednisolonacetat 80 mg/2 ml, injektionsvätska, suspension, flaska | Has concentration strength denominator unit | mL | false | Inferred relationship | Some | 2 | |
| lidokainhydroklorid 20 mg/2 ml + metylprednisolonacetat 80 mg/2 ml, injektionsvätska, suspension, flaska | Has presentation strength denominator unit (attribute) | mL | false | Inferred relationship | Some | 1 | |
| lidokainhydroklorid 20 mg/2 ml + metylprednisolonacetat 80 mg/2 ml, injektionsvätska, suspension, flaska | har nämnarvärde som visar koncentrationsstyrka | 1 (qualifier value) | false | Inferred relationship | Some | 2 | |
| lidokainhydroklorid 20 mg/2 ml + metylprednisolonacetat 80 mg/2 ml, injektionsvätska, suspension, flaska | Is a | Product containing methylprednisolone in parenteral dose form (medicinal product form) | false | Inferred relationship | Some | ||
| lidokainhydroklorid 20 mg/2 ml + metylprednisolonacetat 80 mg/2 ml, injektionsvätska, suspension, flaska | Has concentration strength numerator unit | mg | false | Inferred relationship | Some | 1 | |
| lidokainhydroklorid 20 mg/2 ml + metylprednisolonacetat 80 mg/2 ml, injektionsvätska, suspension, flaska | Has unit of presentation | Vial (unit of presentation) | false | Inferred relationship | Some | ||
| lidokainhydroklorid 20 mg/2 ml + metylprednisolonacetat 80 mg/2 ml, injektionsvätska, suspension, flaska | Has manufactured dose form | Suspension for injection | false | Inferred relationship | Some | ||
| lidokainhydroklorid 20 mg/2 ml + metylprednisolonacetat 80 mg/2 ml, injektionsvätska, suspension, flaska | Is a | Lidocaine-containing product in parenteral dose form | false | Inferred relationship | Some | ||
| lidokainhydroklorid 20 mg/2 ml + metylprednisolonacetat 80 mg/2 ml, injektionsvätska, suspension, flaska | räkning av bas i aktiv ingrediens | 2 (qualifier value) | false | Inferred relationship | Some | ||
| lidokainhydroklorid 20 mg/2 ml + metylprednisolonacetat 80 mg/2 ml, injektionsvätska, suspension, flaska | Has presentation strength numerator unit | mg | false | Inferred relationship | Some | 2 | |
| lidokainhydroklorid 20 mg/2 ml + metylprednisolonacetat 80 mg/2 ml, injektionsvätska, suspension, flaska | Has concentration strength denominator unit | mL | false | Inferred relationship | Some | 1 | |
| lidokainhydroklorid 20 mg/2 ml + metylprednisolonacetat 80 mg/2 ml, injektionsvätska, suspension, flaska | har nämnarvärde som visar styrka | 2 (qualifier value) | false | Inferred relationship | Some | 2 | |
| lidokainhydroklorid 20 mg/2 ml + metylprednisolonacetat 80 mg/2 ml, injektionsvätska, suspension, flaska | Is a | Product containing lidocaine and methylprednisolone (medicinal product) | false | Inferred relationship | Some | ||
| lidokainhydroklorid 20 mg/2 ml + metylprednisolonacetat 80 mg/2 ml, injektionsvätska, suspension, flaska | Has concentration strength numerator unit | mg | false | Inferred relationship | Some | 2 | |
| lidokainhydroklorid 20 mg/2 ml + metylprednisolonacetat 80 mg/2 ml, injektionsvätska, suspension, flaska | har nämnarvärde som visar styrka | 2 (qualifier value) | false | Inferred relationship | Some | 1 | |
| lidokainhydroklorid 20 mg/2 ml + metylprednisolonacetat 80 mg/2 ml, injektionsvätska, suspension, flaska | Has presentation strength numerator unit | mg | false | Inferred relationship | Some | 1 | |
| lidokainhydroklorid 20 mg/2 ml + metylprednisolonacetat 80 mg/2 ml, injektionsvätska, suspension, flaska | har nämnarvärde som visar koncentrationsstyrka | 1 (qualifier value) | false | Inferred relationship | Some | 1 | |
| lidokainhydroklorid 20 mg/2 ml + metylprednisolonacetat 80 mg/2 ml, injektionsvätska, suspension, flaska | Has presentation strength denominator unit (attribute) | mL | false | Inferred relationship | Some | 2 | |
| lidokainhydroklorid 20 mg/2 ml + metylprednisolonacetat 80 mg/2 ml, injektionsvätska, suspension, flaska | har täljarvärde som visar styrka | 80 (qualifier value) | false | Inferred relationship | Some | 1 | |
| lidokainhydroklorid 20 mg/2 ml + metylprednisolonacetat 80 mg/2 ml, injektionsvätska, suspension, flaska | har täljarvärde som visar styrka | 20 (qualifier value) | false | Inferred relationship | Some | 2 | |
| lidokainhydroklorid 20 mg/2 ml + metylprednisolonacetat 80 mg/2 ml, injektionsvätska, suspension, flaska | har täljarvärde för koncentrationsstyrka | 40 (qualifier value) | false | Inferred relationship | Some | 1 | |
| lidokainhydroklorid 20 mg/2 ml + metylprednisolonacetat 80 mg/2 ml, injektionsvätska, suspension, flaska | Has precise active ingredient | Lidocaine hydrochloride | false | Inferred relationship | Some | 2 | |
| lidokainhydroklorid 20 mg/2 ml + metylprednisolonacetat 80 mg/2 ml, injektionsvätska, suspension, flaska | har täljarvärde för koncentrationsstyrka | 10 (qualifier value) | false | Inferred relationship | Some | 2 | |
| lidokainhydroklorid 20 mg/2 ml + metylprednisolonacetat 80 mg/2 ml, injektionsvätska, suspension, flaska | Has basis of strength substance (attribute) | Lidocaine hydrochloride | false | Inferred relationship | Some | 2 | |
| lidokainhydroklorid 20 mg/2 ml + metylprednisolonacetat 80 mg/2 ml, injektionsvätska, suspension, flaska | Has precise active ingredient | Methylprednisolone acetate | false | Inferred relationship | Some | 1 | |
| lidokainhydroklorid 20 mg/2 ml + metylprednisolonacetat 80 mg/2 ml, injektionsvätska, suspension, flaska | Has basis of strength substance (attribute) | Methylprednisolone acetate | false | Inferred relationship | Some | 1 | |
| lidokainhydroklorid 20 mg/2 ml + metylprednisolonacetat 80 mg/2 ml, injektionsvätska, suspension, flaska | Is a | Product containing glucocorticoid (product) | false | Inferred relationship | Some | ||
| lidokainhydroklorid 20 mg/2 ml + metylprednisolonacetat 80 mg/2 ml, injektionsvätska, suspension, flaska | Is a | Product manufactured as parenteral dose form (product) | false | Inferred relationship | Some | ||
| lidokainhydroklorid 20 mg/2 ml + metylprednisolonacetat 80 mg/2 ml, injektionsvätska, suspension, flaska | Is a | Nitrogen and/or nitrogen compound-containing product | false | Inferred relationship | Some | ||
| lidokainhydroklorid 20 mg/2 ml + metylprednisolonacetat 80 mg/2 ml, injektionsvätska, suspension, flaska | Is a | Product containing pregnane (product) | false | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
Concept inactivation indicator reference set
POSSIBLY EQUIVALENT TO association reference set (foundation metadata concept)
FHIR